ADDRESSING VACCINE INEQUITY DURING THE COVID-19 PANDEMIC: THE TRIPS INTELLECTUAL PROPERTY WAIVER PROPOSAL AND BEYOND

Abstract This article examines global vaccine inequity during the COVID-19 pandemic. We critique intellectual property (IP) law under 1994 WTO TRIPS Agreement, and specifically, role that IP has played in enabling inequities of production, distribution pricing context. Given failure international response mechanisms, including COVAX C-TAP, to address inequity, we argue waiver proposal should be viewed as offering a necessary proportionate legal measure for clearing barriers cannot achieved by existing flexibilities. Finally, reflect on debate wider context need boost pandemic preparedness.